Breathe Easy: Inside the Invisible Technology Protecting Cancer Patients

Breathe Easy: Inside the Invisible Technology Protecting Cancer Patients

25 years ago, a technical team of 3 built a better way to fight cancer from an attic in London. Today, Vision RT’s light-based tracking technology is quietly becoming the new standard of care in radiation therapy worldwide.

Radiation therapy is one of the most effective weapons in oncology — but it has always carried an invisible risk. Patients move. They breathe. A shift of even a single millimeter can redirect a high-energy beam from a tumor to a healthy organ. For decades, the medical community managed this with blunt instruments: permanent tattoos etched into a patient’s skin to align the machine, or rigid immobilization masks — some bolted directly to a treatment table — that clinicians acknowledged caused so much distress that some patients chose to abandon treatment rather than endure them. In communities where tattoos are religiously or culturally forbidden, the choice was even starker.

Dr. Norman Smith saw a better way. In 2001, from a small office in London, together with his co-founders he pioneered Surface Guided Radiation Therapy — a technology that uses 3D structured-light cameras to project  light onto a patient’s skin, creating a continuously updated digital surface, comprising thousands of points, accurate to less than 0.5 millimeter (the thickness of a sheet of paper). If the patient moves mid-beam, AlignRT detects it instantly and automatically pauses the radiation. When the patient returns to position, treatment resumes. No tattoos. No masks. No bolts.

Twenty-five years on, Vision RT has grown from a converted attic to an international company with 400+ staff, 3,500+ active systems, and a presence in 24 of the top 25 U.S. hospitals for cancer — as ranked by U.S. News & World Report. SGRT has become standard of care, with AlignRT being in use on almost half of all treatment machines in the US. The company has won five King’s Awards for Enterprise, the UK’s most prestigious business honor. And it has expanded far beyond its original AlignRT system to offer solutions across the entire radiation therapy workflow: MapRT for optimized and enhanced treatment planning, SimRT for simulation, and DoseRT — a breakthrough system that lets clinicians visualize exactly where the radiation dose is going in real time, catching errors before they reach the patient.

An example of compelling clinical benefit: for left-sided breast cancer patients, radiation proximity to the heart has historically caused post-treatment cardiac defects in up to 27% of cases. AlignRT, combined with the Deep Inspiration Breath Hold (DIBH) technique — where patients take a controlled deep breath to physically move the heart away from the breast — has been shown in peer-reviewed studies to bring that figure to 0%. For cancer clinics, oncologists, and the millions of patients and families facing cancer treatment.

Facebook
Twitter
LinkedIn
Pinterest